Approved anti-IL17 ( R ) drugs include : Brodalumab ( Siliq ) approved for psoriasis .
Brodalumab ( Siliq ) is an antibody to the receptor .
Approved anti-IL17 ( R ) drugs include : Brodalumab ( Siliq ) , an antibody to the receptor , approved for psoriasis .